U.S. Tech Hardware Stock News

Earlier this week, Coinbase Global launched U.S. stock and ETF trading for millions of users, allowing zero-commission, 24/5 access to thousands of equities alongside cryptocurrencies and integrating one-click trading through a new partnership with Yahoo Finance. This move advances Coinbase’s aim to become an “Everything Exchange,” potentially deepening user engagement by unifying traditional and digital assets within a single platform and data ecosystem. We’ll now examine how Coinbase’s...

Sea Limited (NYSE:SE) has entered into a partnership with Google to build AI driven tools for its Shopee e commerce platform and Garena gaming unit in Southeast Asia. The collaboration focuses on autonomous shopping experiences for users and advanced AI capabilities for game development. The news arrives with Sea shares trading around $110.9, drawing attention to how AI adoption could affect its core businesses. Sea, trading on the NYSE under ticker SE, is in focus as it teams up with...

Veracyte FY 2025 Earnings Snapshot Veracyte (VCYT) has wrapped up FY 2025 with fourth quarter revenue of US$140.6 million and basic EPS of US$0.52, alongside net income of US$41.1 million, putting a clear spotlight on its profitability profile. The company has seen revenue move from US$118.6 million in Q4 2024 to US$140.6 million in Q4 2025, while basic EPS shifted from US$0.07 to US$0.52 over the same period, feeding into trailing twelve month EPS of US$0.84 on revenue of US$517.1 million...

Goldman Sachs Group (NYSE:GS) is rolling out AI powered trading surveillance tools to monitor trading activity and support its compliance efforts. At the same time, Senator David McCormick has sold his and his wife's holdings in Goldman Sachs, following his prior executive role at the firm and his current Senate banking assignments. The combination of new AI driven oversight and insider selling is drawing fresh attention to how Goldman Sachs manages risk, governance and regulatory...

Array Technologies (ARRY) has just wrapped up FY 2025 with Q4 revenue of US$226.0 million and a basic EPS loss of US$1.06, alongside trailing twelve month revenue of about US$1.3 billion and a TTM basic EPS loss of US$0.73. The company has seen quarterly revenue range from US$231.4 million in Q3 2024 to US$393.5 million in Q3 2025, while basic EPS has swung between a loss of US$1.02 in Q3 2024 and a profit of US$0.19 in Q2 2025. This sets up a story where investors are watching how...

Antero Resources (NYSE:AR) has completed the sale of substantially all of its Utica Shale oil and gas assets. The company is using the proceeds to redeem a significant portion of its outstanding senior notes and reduce debt. The transaction marks a major shift in Antero's portfolio and balance sheet structure. Antero Resources, trading at $34.38, has seen mixed share performance, with a 1.9% decline over the past week, flat returns over 30 days, and a 0.5% gain year to date. Over longer...

Fastenal (NasdaqGS:FAST) reported a 59% year over year increase in CEO Daniel L. Florness's compensation in a new SEC filing. Multiple insiders have purchased Fastenal stock over the past six months. The company has been awarded nearly $8 million in government contracts over the last year. Fastenal, trading at around $45.68 per share, has seen its stock return 13.0% year to date and 25.9% over the past year, with longer term gains of 85.9% over three years and 133.3% over five years. In...

The FDA has issued draft guidance aimed at accelerating approvals for genome editing and RNA based therapies. The proposal introduces master protocols that could allow multiple gene editing products to be evaluated within a single trial framework. This draft guidance directly affects companies using CRISPR/Cas9 platforms, including CRISPR Therapeutics and its CASGEVY program. For investors watching CRISPR Therapeutics (NasdaqGM:CRSP), the timing of this FDA draft guidance comes as the...

Greg Abel has taken over as CEO of Berkshire Hathaway (NYSE:BRK.A), issuing his first shareholder letter and outlining how he plans to run the company after Warren Buffett. Berkshire’s utility subsidiary PacifiCorp is facing significant wildfire related liabilities, and Abel is pursuing legislative and regulatory changes that could affect how those risks are shared and managed. These developments mark the first major leadership transition at Berkshire in decades and come as utility operators...

Intellia Therapeutics (NTLA) closed FY 2025 with Q4 revenue of US$23.0 million and a basic EPS loss of US$0.83, as the company continued to invest heavily in its gene editing pipeline. Over the last six quarters, revenue has moved from US$9.1 million in Q3 2024 to US$23.0 million in Q4 2025, while quarterly basic EPS losses have ranged between US$0.83 and US$1.34. This has left margins firmly in loss-making territory even as the top line scaled up. See our full analysis for Intellia...

Earlier in February 2026, Fitch Ratings affirmed Ally Financial’s Long-Term Issuer Default Rating at BBB- while revising its outlook to Positive, reflecting the rating agency’s view of improving profitability, credit performance, and capital strength following Ally’s sharpened focus on auto and corporate lending. By selling its personal loans and card portfolios and allowing its mortgage book to run off, Ally is concentrating on core lending businesses in a way that rating agencies now view...

Palo Alto Networks agreed to acquire CyberArk and Koi Security to deepen its AI security platform. The company expanded its Nvidia integration and launched Unit 42 Managed XSIAM 2.0 to push further into AI driven cybersecurity. These moves signal a shift toward platform consolidation that could affect profitability and integration complexity in the near term. Palo Alto Networks (NasdaqGS:PANW) is making an aggressive push into AI centered cybersecurity as its share price sits at $149.4. The...

Revolve Group (RVLV) has attracted fresh attention after recent trading action left the stock with mixed short term performance, including a decline over the past month alongside gains over the past 3 months and the past year. See our latest analysis for Revolve Group. At a share price of $26.30, Revolve Group’s recent 1 day share price return of 7.96% and 7 day share price return of 4.91% contrast with a 30 day share price return of 9.50% and a flat 1 year total shareholder return of 0.19%...

If you are wondering whether Macy's at around US$20.35 is priced attractively or not, this article will walk you through what the current market price might be implying about its value. The stock has seen mixed recent performance, with a 7.5% decline over the last 7 days and a 0.1% decline over 30 days, while still showing a 51.7% return over 1 year and a 59.9% return over 5 years. Recent headlines around Macy's have focused on the long running discussion about the future of department...

Bristol Myers Squibb (NYSE:BMY) reported positive Phase 2 results for Reblozyl in treating anemia in alpha thalassemia patients. The company announced FDA acceptance of its new drug application for iberdomide in relapsed or refractory multiple myeloma. Iberdomide received Breakthrough Therapy Designation and Priority Review from the FDA. Bristol Myers Squibb, a large biopharma company focused on hematology and oncology among other areas, is adding fresh clinical momentum to its pipeline...

Hinge Health (NYSE:HNGE) President James Pursley recently sold company shares, extending a pattern of insider transactions over the past year. The latest sale adds to ongoing insider activity that investors may track alongside the company’s trading performance and business developments. Hinge Health, trading at $43.67 at the last close, has seen its share price move 4.2% over the past week and 8.1% over the past month. Year to date, the stock shows a 4.1% decline, which gives investors some...

Eli Lilly (NYSE:LLY) reported that its oral GLP-1 candidate orforglipron outperformed Novo Nordisk’s oral semaglutide in a head to head Phase 3 trial in adults with type 2 diabetes. The trial results showed superior blood sugar control and weight loss for orforglipron compared with the rival therapy. The EMA’s Committee for Medicinal Products for Human Use issued a positive opinion to extend Olumiant’s use to adolescents with severe alopecia areata in Europe. Eli Lilly is a large global...

Citi recently placed KLA Corp on a 30‑day positive Catalyst Watch ahead of its 12 March Investor Day in New York, citing expectations for a stronger long‑term financial model and potential product announcements. This fresh attention comes as KLA benefits from accelerating demand for advanced packaging and inspection tools tied to AI and leading‑edge chip production. We'll now examine how Citi's Catalyst Watch and expectations for KLA's Investor Day may influence the company's existing...

Ingredion (INGR) is back on investors’ radar after appointing Univar Solutions as the exclusive distributor for its pharmaceutical starches in the United States and Canada, expanding access to its excipient portfolio across pharmaceutical and nutraceutical customers. See our latest analysis for Ingredion. The Univar agreement arrives after a steady build in recent momentum, with Ingredion’s 90 day share price return of 8.93% and year to date share price return of 6.69%, even as the 1 year...

In February 2026, Visteon Corporation reported fourth-quarter and full-year 2025 results showing softer net income and earnings per share alongside slightly lower annual sales of US$3.77 billion, while its Board raised the quarterly dividend to US$0.375 per share payable on March 16, 2026, and confirmed 2026 sales guidance of US$3.63 billion to US$3.83 billion. At the same time, Visteon completed a US$225.93 million share repurchase program that retired about 7.17% of its shares, signaling a...

Marriott International (NasdaqGS:MAR) has secured more than 100 new hotel deals in India, marking record expansion milestones in South Asia. The company reports a strong development pipeline in the wider Asia Pacific region, including targeted growth in Vietnam. Marriott has reopened the JW Marriott Atlanta Downtown after a major renovation, adding fresh capacity to its luxury portfolio in the United States. Marriott International, known for its global hotel and lodging brands, is leaning...

In February 2026, Klaviyo announced a partnership with Google that connects Google’s search, ads, AI, and RCS messaging with Klaviyo’s real-time customer data platform to power AI‑driven, autonomous customer experiences across discovery, purchase, service, and loyalty. A distinctive element of the collaboration is Klaviyo’s early access to Google’s Search‑to‑RCS experience, allowing consumers to launch AI‑powered brand conversations directly from search results, with every interaction...

If you are wondering whether W. R. Berkley at around US$71.58 is giving you a fair deal or asking too much, the next sections will walk through what the current price really implies. The stock has delivered returns of 1.8% over the last 7 days, 6.5% over 30 days, 3.2% year to date and 18.5% over 1 year, with longer term figures of 71.6% over 3 years and 157.1% over 5 years that may influence how investors think about upside and risk today. Recent coverage of W. R. Berkley has focused on its...

Liberty Live Holdings (LLYV.K) is back in focus after reporting full year 2025 results, with sales and revenue of US$381.95 million and a net loss of US$86.97 million, compared with the prior year. See our latest analysis for Liberty Live Holdings. The earnings update appears to have reinforced buying interest, with Liberty Live Holdings posting a 30 day share price return of 14.32% and a 90 day share price return of 22.89%. The 1 year total shareholder return stands at 34.47%, suggesting...